>

CME Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:3em;padding-top: 40px;;'>CME</div>
CME -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding CME Group is 'Hold'. Macroaxis provides CME buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CME positions. The advice algorithm takes into account all of CME Group available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CME buy-and-hold perspective. Continue to CME Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Equity
Refresh
Sell CMEBuy CME
Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon CME Group has a risk adjusted performance of 0.0856, jensen alpha of 0.0886, total risk alpha of 0.1752, sortino ratio of 0.1409 and treynor ratio of (2.17)
Macroaxis provides buy, hold, or sell suggestion on CME Group to complement and cross-verify current analyst consensus on CME Group. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the perspective of investors current risk tolerance and investing horizon. To make sure CME is not overpriced, please confirm all CME Group fundamentals, including its Current Valuation, Price to Book, Cash and Equivalents, as well as the relationship between Shares Owned by Institutions and Gross Profit . Given that CME Group has Price to Earning of 35.41 , we suggest you validate CME Group market performance and probability of bankruptcy to make sure the company can sustain itself in the future given your prevailing risk tolerance and investing horizon.

CME Trading Alerts and Improvement Suggestions

Over 91.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Payment of 427 shares by Vroman Ken of CME subject to Rule 16b-3

CME current analysts recommendations

Target Median Price218.14
Target Mean Price219.58
Recommendation Mean2.50
Target High Price249.00
Number Of Analyst Opinions16
Target Low Price177.00

CME Returns Distribution Density

Mean Return0.10Value At Risk1.78
Potential Upside2.11Standard Deviation1.22
 Return Density 
    
  Distribution 

Institutional Investors

Security TypeSharesValue
Capital World InvestorsCommon Shares35.8 M7.2 B
Vanguard Group IncCommon Shares28.6 M5.7 B
Blackrock IncCommon Shares25.5 M5.1 B
State Street CorpCommon Shares16.4 M3.3 B
Capital Research Global InvestorsCommon Shares13.6 M2.7 B
Capital International InvestorsCommon Shares12.1 M2.4 B
Fmr LlcCommon Shares7.8 M1.6 B

CME Greeks

α
Alpha over DOW
=0.09
β
Beta against DOW=0.04
σ
Overall volatility
=1.21
Ir
Information ratio =0.13

CME Volatility Alert

CME Group has relatively low volatility with skewness of 1.28 and kurtosis of 6.24. However, we advise all investors to independently investigate CME Group to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare CME to competition

CME Fundamental Vs Peers

FundamentalsCMEPeer Average
Return On Equity8.12 (0.31) 
Return On Asset2.12 (0.14) 
Profit Margin43.48 (1.27) 
Operating Margin62.94 (5.51) 
Current Valuation76.79 B16.62 B
Shares Outstanding358.36 M571.82 M
Shares Owned by Insiders1.56 10.09 
Shares Owned by Institutions90.67 39.21 
Number of Shares Shorted6.49 M4.71 M
Price to Earning35.41 28.72 
Price to Book2.86 9.51 
Price to Sales15.41 11.42 
Revenue4.87 B9.43 B
Gross Profit4.87 B27.38 B
EBITDA3.06 B3.9 B
Net Income2.12 B570.98 M
Cash and Equivalents1.63 B2.7 B
Cash per Share4.57 5.01 
Total Debt3.74 B5.32 B
Debt to Equity14.30 48.70 
Current Ratio1.03 2.16 
Book Value Per Share73.10 1.93 K
Cash Flow from Operations3.26 B971.22 M
Short Ratio4.98 4.00 
Earnings Per Share5.91 3.12 
Price to Earnings To Growth5.56 4.89 
Number of Employees4.59 K18.84 K
Beta0.08-0.15
Market Capitalization75.01 B19.03 B
Total Asset67.36 B29.47 B
Retained Earnings4.97 B9.33 B
Working Capital1.08 B1.48 B
Current Asset37.9 B9.34 B
   Payment of 427 shares by Vroman Ken of CME subject to Rule 16b-3 [view details]